NVCR:NGS-NovoCure Limited (USD)

EQUITY | Others | Nasdaq Global Select

Last Closing

USD 95.75

Change

+0.74 (+0.78)%

Market Cap

USD 0.81B

Volume

0.43M

Analyst Target

USD 90.43
Analyst Rating

N/A

ducovest Verdict

Verdict

About

NovoCure Ltd is a commercial stage oncology company. It is engaged in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-02-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

-0.97 (-0.55%)

USD 22.08B
ACWI iShares MSCI ACWI ETF

-0.15 (-0.14%)

USD 19.51B
IBIT iShares Bitcoin Trust

+1.45 (+4.17%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.07 (+0.39%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.24 (-0.46%)

USD 11.10B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 2.97B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.89B
TDI Touchstone Dynamic Internation..

-0.03 (-0.11%)

USD 2.81B
IBTF iShares iBonds Dec 2025 Term T..

N/A

USD 2.19B
USCL iShares Climate Conscious & Tr..

-0.09 (-0.15%)

USD 2.01B

ETFs Containing NVCR

DWAQ 0.00 % 0.60 %

N/A

N/A
NIFE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.62% 85% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.62% 85% B 80% B-
Trailing 12 Months  
Capital Gain 80.49% 93% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 80.49% 93% A 92% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 72.45% 95% A 96% N/A
Dividend Return 72.45% 95% A 96% N/A
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 78.55% 9% A- 10% F
Risk Adjusted Return 92.23% 94% A 88% B+
Market Capitalization 0.81B 98% N/A 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Others) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio 49.38 3% 3%
Price / Cash Flow Ratio -5,041.82 100% 100%
Price/Free Cash Flow Ratio -3,399.14 100% 100%
Management Effectiveness  
Return on Equity -17.77% 38% 33%
Return on Invested Capital -17.87% 39% 27%
Return on Assets -1.54% 45% 38%
Debt to Equity Ratio 133.05% 23% 16%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.